Your browser doesn't support javascript.
loading
Allergen Immunotherapy in the Era of SARS-CoV-2.
Compalati, E; Erlewyn-Lajeunesse, M; Runa Ali, F; Ojeda Fernández, P; Garcia Nuñez, I; Frati, F; Mistrello, G.
Affiliation
  • Compalati E; Lofarma Scientific Department, Lofarma S.p.A., Milan.
  • Erlewyn-Lajeunesse M; Paediatric Allergy & Immunology, Southampton Children's Hospital, Southampton, UK.
  • Runa Ali F; Barts Health NHS Trust, London, UK.
  • Ojeda Fernández P; Clínica de Asma y Alergia Dres. Ojeda, Madrid, Spain.
  • Garcia Nuñez I; Hospital Quirónsalud, Córdoba, Spain.
  • Frati F; Hospital Quirónsalud, Campo de Gibraltar, Palmones, Spain.
  • Mistrello G; Lofarma Scientific Department, Lofarma S.p.A., Milan.
J Investig Allergol Clin Immunol ; 30(6): 459-461, 2020.
Article in En | MEDLINE | ID: mdl-32394897
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Desensitization, Immunologic / SARS-CoV-2 / COVID-19 / Hypersensitivity Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Desensitization, Immunologic / SARS-CoV-2 / COVID-19 / Hypersensitivity Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Type: Article